IHD |
ischaemic heart disease |
HF |
heart failure |
TGF-β |
Transcription Growth Factor Beta |
LC-MS/MS |
Liquid Chromatography Tandem Mass Spectrometry |
ISCM |
ischaemic cardiomyopathy |
NF |
Non-failure |
MI |
myocardial infarction |
ECM |
extracellular matrix |
FDA |
Food and Drug Administration |
LV |
left ventricular |
MS |
mass spectrometry |
LAD |
left anterior descending |
UK |
United Kingdom |
BPM |
Beats per minute |
ECG |
Electrocardiogram |
DMEM |
Dulbecco’s Modified Eagle Medium |
FBS |
fetal bovine serum |
BCA |
Bicinchoninic acid assay |
DTT |
1.4-dithiothreitol |
IAA |
iodoacetamide |
TFA |
trifluoroacetic acid |
AcN |
acetonitrile |
DDA |
Data dependent acquisition |
DIA |
Data independent acquisition |
TIMS |
trapped ion mobility spectrometry |
PASEF |
Parallel accumulation serial fragmentation |
KEGG |
Kyoto Encyclopedia of Genes and Genomes |
RNA |
Ribonucleic acid |
Dclk1 |
doublecortin-like kinase 1 |
Antxr1 |
anthrax toxin receptor 1 |
Prepl |
prolyl endopeptidase-like protein |
Lox |
protein-lysine 6-oxidase |
Loxl3 |
Lysyl oxidase homolog 3 |
Col6a1 |
Protein collagen, type VI, alpha 1 |
ER |
Endoplasmic reticulum |
NF-kB |
Nuclear factor kappa-light-chain-enhancer of activated B cells |